Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 11/6/2025

Initial Management of Severe Hemoptysis

Immediate Airway Management

  • The American Thoracic Society recommends intubating immediately with a single-lumen cuffed endotracheal tube, rather than a double-lumen tube, to allow bronchoscopic suctioning and removal of large obstructing clots, which is the most common cause of respiratory insufficiency and death from asphyxiation in massive hemoptysis, with a high level of evidence 3, 4, 1
  • Selective right or left mainstem intubation can be performed to protect the nonbleeding lung if the bleeding side is identified, with a moderate level of evidence 3, 4
  • The American College of Chest Physicians recommends avoiding BiPAP entirely, as positive pressure ventilation can worsen bleeding, with a high level of evidence 1, 5
  • Establishing large-bore IV access for resuscitation is crucial in the management of severe hemoptysis, with a high level of evidence 5

Risk Stratification and Clinical Decision-Making

  • For clinically unstable patients with massive hemoptysis, the American College of Radiology recommends proceeding directly to bronchial artery embolization (BAE) without delay, as delaying BAE significantly increases mortality, with a high level of evidence 1, 2, 5
  • The rate of bleeding correlates more closely with mortality than total volume, with a moderate level of evidence 1, 2, 5
  • For clinically stable patients, obtaining a chest radiograph to assess endotracheal tube placement and extent of lung involvement is recommended, with a moderate level of evidence 1, 2, 5

Bronchoscopy: Diagnostic and Therapeutic Role

  • The American Thoracic Society recommends performing bronchoscopy immediately in stable patients to identify the anatomic site and side of bleeding, nature of the bleeding source, severity, and therapeutic feasibility, with a diagnostic yield of 70-80%, with a high level of evidence 2, 5
  • Bronchoscopic temporizing measures, such as wedging the bronchoscope tip tightly into the bleeding bronchus for tamponade, followed by instillation of iced saline solution to constrict blood vessels, can stop bleeding in many patients, with a moderate level of evidence 6, 4, 1
  • Bronchial blockade balloons can be used to tamponade the bronchus, potentially requiring 24-48 hours in place, with a moderate level of evidence 6, 4
  • Bronchoscopic-guided topical hemostatic tamponade therapy using oxidized regenerated cellulose mesh can immediately arrest hemoptysis in 98% of patients, with a high level of evidence 6, 4, 2

Bronchial Artery Embolization

  • BAE achieves immediate hemostasis in 73-99% of cases, as over 90% of massive hemoptysis originates from systemic arterial supply, with a high level of evidence 7, 1, 2
  • CT chest with IV contrast is the preferred initial diagnostic test for stable patients, with diagnostic accuracy of 80-90% and superior to bronchoscopy, with a high level of evidence 1, 2, 5
  • CT angiography is the standard of care for arterial planning if BAE is being considered, with a high level of evidence 5
  • Recurrence of bleeding occurs in 10-55% of cases after BAE, requiring close follow-up, but repeat BAE shows no increased risk of morbidity or mortality, with a moderate level of evidence 7, 1, 2, 5

Medical Management

  • The American College of Chest Physicians recommends stopping NSAIDs immediately in patients with severe hemoptysis, as they impair platelet function and worsen bleeding, with a high level of evidence 1, 2, 5
  • Stopping all anticoagulants during active hemoptysis is recommended, with a high level of evidence 5
  • Stopping all airway clearance therapies immediately in massive hemoptysis to allow clot formation is recommended, with a high level of evidence 1, 5
  • Administering antibiotics for patients with at least mild hemoptysis is recommended, as bleeding may represent a pulmonary exacerbation or superimposed bacterial infection, with a moderate level of evidence 1, 2, 5

Intensive Care Monitoring

  • The American Thoracic Society recommends admitting all patients to intensive care for monitoring of coagulation parameters, hemoglobin levels, blood gases, and ongoing bleeding, with a high level of evidence 5
  • Actively warming the patient and all transfused fluids is recommended, with a moderate level of evidence 5
  • Starting venous thromboprophylaxis as soon as bleeding is controlled is recommended, with a moderate level of evidence 5

Critical Pitfalls to Avoid

  • The American College of Radiology recommends never delaying airway protection in favor of diagnostic procedures when respiratory distress is present, with a high level of evidence 1, 5
  • Never performing bronchoscopy before BAE in clinically unstable patients with massive hemoptysis is recommended, as this delay significantly increases mortality, with a high level of evidence 2, 5
  • Never using double-lumen endotracheal tubes is recommended, as they are more difficult to place, have smaller lumens, and do not permit therapeutic bronchoscopy through each side, with a moderate level of evidence 3, 4, 8
  • Do not instill vasoactive agents like epinephrine if bleeding is brisk, as they are unlikely to help, with a moderate level of evidence 6, 4